201 related articles for article (PubMed ID: 19497246)
1. Metabolic risk factors in drug-naive patients with first-episode psychosis.
Verma SK; Subramaniam M; Liew A; Poon LY
J Clin Psychiatry; 2009 Jul; 70(7):997-1000. PubMed ID: 19497246
[TBL] [Abstract][Full Text] [Related]
2. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
[TBL] [Abstract][Full Text] [Related]
3. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan.
Huang MC; Lu ML; Tsai CJ; Chen PY; Chiu CC; Jian DL; Lin KM; Chen CH
Acta Psychiatr Scand; 2009 Oct; 120(4):274-80. PubMed ID: 19426161
[TBL] [Abstract][Full Text] [Related]
5. Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: one-month prospective evaluation.
Tarricone I; Serretti A; Gozzi BF; Mandelli L; Grieco D; Mellini L; Biagini S; Berti B; Berardi D
Psychiatry Res; 2008 Jan; 157(1-3):269-71. PubMed ID: 17961714
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
Brunero S; Lamont S; Fairbrother G
Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
8. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
[No Abstract] [Full Text] [Related]
10. Metabolic abnormalities in an early psychosis service: a retrospective, naturalistic cross-sectional study.
Curtis J; Henry C; Watkins A; Newall H; Samaras K; Ward PB
Early Interv Psychiatry; 2011 May; 5(2):108-14. PubMed ID: 21470374
[TBL] [Abstract][Full Text] [Related]
11. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up.
Medved V; Kuzman MR; Jovanovic N; Grubisin J; Kuzman T
J Psychopharmacol; 2009 Nov; 23(8):915-22. PubMed ID: 18635691
[TBL] [Abstract][Full Text] [Related]
13. Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis.
Verma S; Liew A; Subramaniam M; Poon LY
Aust N Z J Psychiatry; 2009 Sep; 43(9):812-7. PubMed ID: 19670054
[TBL] [Abstract][Full Text] [Related]
14. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and mental illness.
Newcomer JW
Am J Manag Care; 2007 Nov; 13(7 Suppl):S170-7. PubMed ID: 18041878
[TBL] [Abstract][Full Text] [Related]
17. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
[TBL] [Abstract][Full Text] [Related]
20. Body mass index as a screening test for metabolic syndrome in schizophrenia and schizoaffective disorders.
Tirupati S; Chua LE
Australas Psychiatry; 2007 Dec; 15(6):470-3. PubMed ID: 17999257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
